Clinical Trial

Leucine Supplementation Strategies to Enhance Muscle Anabolic Responses in Older Age

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 4, 2026 (before its estimated August 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
Sarcopenia describes the progressive decline of muscle mass and strength with advancing age and is associated with increased frailty and morbidity, however we do not currently have an effective treatment. Protein feeding and exercise is known to increase muscle mass, but aged muscle shows a lower response to these stimuli leading to muscle loss over time. We do know that ingesting leucine, a building block of protein, can overcome this reduced response to protein feeding and exercise leading to increased muscle mass in older people. However, we do not understand when the optimum time to ingest leucine is to maximise muscle mass after exercise in older people. In this study we will examine the effect of feeding leucine after exercise either with a meal or between meals.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-21.
Trial Details
NCT Number NCT06567665
Lead Sponsor University of Nottingham
Conditions Muscle Protein Synthesis
Enrollment 10 participants
Start Date 2024-08-05
Primary Completion 2026-08-05 (estimated)
Study Completion 2026-08-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-04